Concepedia

Author

Serkan Menekşe

Manisa Celal Bayar UniversityORCID

Also Known As

Fatih Karataş, Menekşe, Serkan, S Menekse, S Menekşe, S. Menekse, Serkan MENEKŞE, Serkan Menekse, Serkan Menekşe

70

Publications

410

Citations

11

H-Index

11

Concepts

All Affiliations

Manisa Celal Bayar UniversityMuğla UniversitySakarya UniversityAdnan Menderes UniversityEge University
SM

About

Serkan Menekşe is an author at Manisa Celal Bayar University specializing in radiation oncology, cancer research, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

70

2

Pathology

2

2

70

3

Cancer Research

2

2

70

4

Gastroenterology

1

1

39

5

Gastrointestinal Pathology

1

1

39

Serkan Menekşe

×

12

Publications

291

Citations

11

H-Index

YearCitations

Role of increased mean platelet volume (<scp>MPV</scp>) and decreased <scp>MPV</scp>/platelet count ratio as poor prognostic factors in lung cancer

Muhyettin Omar, Özgür Tanrıverdi, Suna Çokmert,

The Clinical Respiratory Journal

2016

51

The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG)

Özgür Tanrıverdi, Esra Kaytan-Saglam, Şükran Ülger,

Medical Oncology

2014

39

Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group

Özgür Tanrıverdi, Esin Oktay, Serdar Kalemci,

Asian Pacific Journal of Cancer Prevention

2015

36

Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group

Özgür Tanrıverdi, Suna Çokmert, Esin Oktay,

Medical Oncology

2014

31

The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG).

Özgür Tanrıverdi, Serkan Menekşe, Fatih Teker,

PubMed

2017

24

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Cengiz Karaçin, Berna Öksüzoğlu, Ayşe Demirci,

BMC Cancer

2023

23

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Seda Kahraman, Enes Erul, Mustafa Seyyar,

Future Oncology

2023

21

Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

Melike Özçelik, Mesut Şeker, Emrah Eraslan,

Tumor Biology

2015

16

Elevated serum lactate dehydrogenase to albumin ratio is a useful poor prognostic predictor of nivolumab in patients with non-small cell lung cancer.

Serkan Menekşe, Engin Kut, Elvina Almuradova

PubMed

2023

15

Impact of systemic inflammatory markers in patients with <i>ALK</i> -positive non-small cell lung cancer treated with crizotinib

Ozgur Olmez, Pınar Gürsoy, Erdem Çubukçu,

Pulmonology

2022

13

Page 1